vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
34.12
-0.42 (-1.22%)
At close: Jul 7, 2026, 4:00 PM EDT
33.71
-0.41 (-1.20%)
After-hours: Jul 7, 2026, 5:28 PM EDT
vTv Therapeutics Market Cap
vTv Therapeutics has a market cap or net worth of $423.41 million as of July 7, 2026. Its market cap has increased by 301.70% in one year.
Market Cap
423.41M
Enterprise Value
325.33M
1-Year Change
301.70%
Ranking
Category
Stock Price
$34.12
Market Cap Chart
Since July 31, 2015, vTv Therapeutics's market cap has increased from $78.12M to $423.41M, an increase of 441.97%. That is a compound annual growth rate of 16.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 423.40M | -14.67% |
| Dec 31, 2025 | 496.22M | 445.90% |
| Dec 31, 2024 | 90.90M | 288.02% |
| Dec 29, 2023 | 23.43M | -56.62% |
| Dec 30, 2022 | 54.01M | -18.92% |
| Dec 31, 2021 | 66.61M | -32.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sagimet Biosciences | 469.93M |
| Artiva Biotherapeutics | 466.93M |
| Evommune | 466.80M |
| Benitec Biopharma | 454.16M |
| Enanta Pharmaceuticals | 439.37M |
| Eupraxia Pharmaceuticals | 438.32M |
| Century Therapeutics | 438.26M |
| Autolus Therapeutics | 420.51M |